Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NIH 4 OTHER 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1

Interventions

pembrolizumab 3 enzalutamide 3 Abiraterone Acetate 3 apalutamide 2 Topotecan 2 Testosterone 2 Itraconazole 2 Docetaxel 2 Cholecalciferol 2 Celecoxib 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 zanubrutinib 1 venetoclax 1 talabostat 1 sargramostim 1 pasireotide 1 olaparib 1 leucoselect phytosome 1 ibrutinib 1 capivasertib 1 acalabrutinib 1 abiraterone 1 Tablets 1 Streptozocin 1 Rituximab 1 Radiosurgery 1 Pluvicto 1 PT-100 dipeptide 1 Oxaliplatin 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × FED × Cystoscopy × Clear all

NCT05796375 2026-05-04

ReplaceCysto

White River Junction Veterans Affairs Medical Center

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡